1. Karimi S, Kakabaraee K, Yazdanbakhsh K, Moradi GR. Effect of cognitive behavioral therapy on subjective well-being of patients with cardiovascular diseases. Journal of Kermanshah University of Medical Sciences 2014; 18: 3147-156. ## 2. Lopez EO, Ballard BD, Jan A. Cardiovascular disease. InStatPearls [Internet] 2023. StatPearls Publishing. Treasure Island (FL): StatPearls Publishing; 2024.## 3. Jani M, Salehi B, Aleyasin SA, Davoudi H. The effectiveness of cognitive behavioral group therapy on quality of life of cardiovascular patients. Journal of Arak University of Medical Sciences 2017; 20(3): 22-30. ## 4. Lotfi MH, Sadr SM, Nemayandea SM. Coronary artery disease risk factors in urban areas of Yazd City, Iran. Asia Pac J Public Health 2011; 23(4): 534-43.## [ DOI:10.1177/1010539509349867] [ PMID] 5. Maleki A, Miri M, Ghanavati R, Bayat M, Montazeri M, Rashidi N, et al. The prevalence of risk factors of coronary artery diseases in CCU ward. Nursing Developement in Health 2013; 3(4-5): 7-13. ## 6. Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease: Analysis of data from the World Health Organization and coronary artery disease risk factors from ncd risk factor collaboration. Circulation: Cardiovascular Quality and Outcomes 2019; 12(6): e005375.## [ DOI:10.1161/CIRCOUTCOMES.118.005375] [ PMID] [ ] 7. Pogosova N, Saner H, Pedersen SS, Cupples ME, McGee H, Höfer S, et al. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac rehabilitation section of the european association of cardiovascular prevention and rehabilitation of the european society of cardiology. European Journal of Preventive Cardiology 2015; 22(10): 1290-306.## [ DOI:10.1177/2047487314543075] [ PMID] 8. Gallagher J, Parenti G, Doyle F. Psychological aspects of cardiac care and rehabilitation: time to wake up to sleep? Current Cardiology Reports 2015; 17: 1-14.## [ DOI:10.1007/s11886-015-0667-8] [ PMID] 9. Neylon A, Canniffe C, Anand S, Kreatsoulas C, Blake GJ, Sugrue D, et al. A global perspective on psychosocial risk factors for cardiovascular disease. Progress in Cardiovascular Diseases 2013; 55(6): 574-81.## [ DOI:10.1016/j.pcad.2013.03.009] [ PMID] 10. Thompson DR, Ski CF, Saner H. Psychosocial assessment and intervention-are we doing enough? Heart & Lung: The Journal of Cardiopulmonary and Acute Care 2018; 47(4): 278-9.## [ DOI:10.1016/j.hrtlng.2018.05.006] [ PMID] 11. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome(Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. American Heart Journal 2008; 155(3): 408-17.## [ DOI:10.1016/j.ahj.2007.11.008] [ PMID] 12. Assad J, Femia G, Pender P, Badie T, Rajaratnam R. Takotsubo Syndrome: A review of presentation, diagnosis and management. Clin Med Insights Cardiol 2022; 16: 11795468211065782.## [ DOI:10.1177/11795468211065782] [ PMID] [ ] 13. Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Current Psychiatry Reports 2016; 18: 101-11.## [ DOI:10.1007/s11920-016-0739-5] [ PMID] [ ] 14. Association AP. Diagnostic and statistical manual of mental disorders(DSM-5). USA: American Psychiatric Pub; 2013.## 15. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014; 129(12): 1350-69.## [ DOI:10.1161/CIR.0000000000000019] [ PMID] 16. Carney RM, Freedland KE. Depression and coronary heart disease. Nature Reviews Cardiology 2017; 14(3): 145-55.## [ DOI:10.1038/nrcardio.2016.181] [ PMID] 17. Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. American Journal of Hypertension 2015; 28(11): 1295-302.## [ DOI:10.1093/ajh/hpv047] [ PMID] [ ] 18. Tully PJ, Cosh SM, Baumeister H. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. Journal of Psychosomatic Research 2014; 77(6): 439-48.## [ DOI:10.1016/j.jpsychores.2014.10.001] [ PMID] 19. Willis TA, Gregory AM. Anxiety disorders and sleep in children and adolescents. Sleep Medicine Clinics 2015; 10(2): 125-31.## [ DOI:10.1016/j.jsmc.2015.02.002] [ PMID] 20. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008; 65(1): 62-71.## [ DOI:10.1001/archgenpsychiatry.2007.4] [ PMID] 21. Shen BJ, Avivi YE, Todaro JF, Spiro A, Laurenceau JP, Ward KD, et al. Anxiety characteristics independently and prospectively predict myocardial infarction in men: the unique contribution of anxiety among psychologic factors. J Am Coll Cardiol 2008; 51(2): 113-9.## [ DOI:10.1016/j.jacc.2007.09.033] [ PMID] 22. Roest AM, Martens EJ, De Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010; 56(1): 38-46.## [ DOI:10.1016/j.jacc.2010.03.034] [ PMID] 23. Karami J, Komasi S, Maesoomi M, Saeedi M. Comparing the effectiveness of two methods of relaxation and interpersonal cognitive problem solving on decreasing anxiety and depression in cardiac rehabilitation patients. Studies in Medical Sciences 2014; 25(5): 298-308. ## 24. Greenberg LS, Goldman RN. Emotion-focused therapy for generalized anxiety disorder. Clinical Handbook of Emotion-Focused Therapy: A CIP record is available from the British Library; 2019; 315.## [ DOI:10.1037/0000112-000] 25. Shihata S, McEvoy PM, Mullan BA. Pathways from uncertainty to anxiety: An evaluation of a hierarchical model of trait and disorder-specific intolerance of uncertainty on anxiety disorder symptoms. J Anxiety Disord 2017; 45: 72-9.## [ DOI:10.1016/j.janxdis.2016.12.001] [ PMID] 26. Sunbul M, Zincir SB, Durmus E, Sunbul EA, Cengiz FF, Kivrak T, et al. Anxiety and depression in patients with coronary artery disease. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2013; 23(4): 345-52.## [ DOI:10.5455/bcp.20130421014758] 27. Ozturk S, Yalvac HD, Sivri N, Ozturk HM, Kılıc Y, Bulut E, et al. Anxiety and depression scores in patients with coronary artery disease and coronary artery ectasia. Int J Cardiol 2015; 186: 299-301.## [ DOI:10.1016/j.ijcard.2015.03.305] [ PMID] 28. Yalvac D, Ozturk S, Sivri N, Kılıç Y, Bulut E, Celik A, et al. Effects of patients anxiety and depression scores on coronary flow in patients with normal coronary arteries. Int J Cardiol 2015; 180: 55-7.## [ DOI:10.1016/j.ijcard.2014.11.153] [ PMID] 29. Dogdu O, Yarlioglues M, Kaya MG, Ardic I, Akpek M, Senarslan O, et al. Relationship between psychosocial status, diabetes mellitus, and left ventricular systolic function in patients with stable multivessel coronary artery disease. Cardiol J 2012; 19(3): 249-55.## [ DOI:10.5603/CJ.2012.0046] [ PMID] 30. Dempe C, Jünger J, Hoppe S, Katzenberger ML, Möltner A, Ladwig KH, et al. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. J Psychosom Res 2013; 74(2): 122-7.## [ DOI:10.1016/j.jpsychores.2012.12.003] [ PMID] 31. Kunschitz E, Friedrich O, Schöppl C, Maitz J, Sipötz J. Illness perception patterns in patients with coronary artery disease. Psychol Health Med 2017; 22(8): 940-6.## [ DOI:10.1080/13548506.2016.1271439] [ PMID] 32. Van Montfort E, Kupper N, Widdershoven J, Denollet J. Person-centered analysis of psychological traits to explain heterogeneity in patient-reported outcomes of coronary artery disease-the THORESCI study. J Affect Disord 2018; 236: 14-22.## [ DOI:10.1016/j.jad.2018.04.072] [ PMID] 33. Maroufizadeh S, Ghaheri A, Omani Samani R. Factors associated with poor quality of life among Iranian infertile women undergoing IVF. Psychology, Health & Medicine 2017; 22(2): 145-51.## [ DOI:10.1080/13548506.2016.1153681] [ PMID] 34. Omani-Samani R, Maroufizadeh S, Ghaheri A, Navid B. Generalized anxiety Disorder-7 (GAD-7) in people with infertility: a reliability and validity study. Middle East Fertility Society Journal 2018; 23(4): 446-9.## [ DOI:10.1016/j.mefs.2018.01.013] 35. Wang JY, Li YS, Chen JD, Liang WM, Yang TC, Lee YC, et al. Investigating the relationships among stressors, stress level, and mental symptoms for infertile patients: A structural equation modeling approach. PloS one 2015; 10(10): e0140581.## [ DOI:10.1371/journal.pone.0140581] [ PMID] [ ] 36. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine 2006; 166(10): 1092-7.## [ DOI:10.1001/archinte.166.10.1092] [ PMID] 37. Wittchen HU, Hoyer J. Generalized anxiety disorder: nature and course. Journal of Clinical Psychiatry 2001; 62: 15-21.## 38. Jordan P, Shedden-Mora MC, Löwe B. Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory. PloS one 2017; 12(8): e0182162.## [ DOI:10.1371/journal.pone.0182162] [ PMID] [ ] 39. Wild B, Eckl A, Herzog W, Niehoff D, Lechner S, Maatouk I, et al. Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. The American Journal of Geriatric Psychiatry 2014; 22(10): 1029-38.## [ DOI:10.1016/j.jagp.2013.01.076] [ PMID] 40. Terrill AL, Hartoonian N, Beier M, Salem R, Alschuler K. The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis. International Journal of MS Care 2015; 17(2): 49-56.## [ DOI:10.7224/1537-2073.2014-008] [ PMID] [ ] 41. Bolgeo T, Di Matteo R, Simonelli N, Dal Molin A, Lusignani M, Bassola B, et al. Psychometric properties and measurement invariance of the 7-item General Anxiety Disorder scale(GAD-7) in an Italian coronary heart disease population. J Affect Disord 2023; 334: 213-9.## [ DOI:10.1016/j.jad.2023.04.140] [ PMID] 42. Zhong QY, Gelaye B, Zaslavsky AM, Fann JR, Rondo MB, Sánchez SE, et al. Diagnostic validity of the generalized anxiety disorder-7 (GAD-7) among pregnant women. PloS One 2015; 10(4): 0125096.## [ DOI:10.1371/journal.pone.0125096] [ PMID] [ ] 43. Tong X, An D, McGonigal A, Park S-P, Zhou D. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res 2016; 120: 31-6.## [ DOI:10.1016/j.eplepsyres.2015.11.019] [ PMID] 44. Myers ND, Ahn S, Jin Y. Sample size and power estimates for a confirmatory factor analytic model in exercise and sport: A Monte Carlo approach. Research Quarterly for Exercise and Sport 2011; 82(3): 412-23.## [ DOI:10.1080/02701367.2011.10599773] [ PMID] 45. Kircanski K, Mortazavi A, Castriotta N, Baker AS, Mystkowski JL, Yi R, et al. Challenges to the traditional exposure paradigm: Variability in exposure therapy for contamination fears. J Behav Ther Exp Psychiatry 2012; 43(2): 745-51.## [ DOI:10.1016/j.jbtep.2011.10.010] [ PMID] 46. Naeinian M, Shaeiri M, Sharif M, Hadian M. To Study reliability and validity for a brief measure for assessing Generalized Anxiety Disorder(GAD-7). CPAP 2011; 2(4): 41-50.## 47. Leech NL, Barrett KC, Morgan GA. SPSS for intermediate statistics: Use and interpretation: 1th ed. Routledge: New York; 2015. [ DOI:10.4324/9780203122778] 48. Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The iranian version of 12-item short form health survey (sf-12): factor structure, internal consistency and construct validity. BMC Public Health 2009; 9(9): 1-10.## [ DOI:10.1186/1471-2458-9-341] [ PMID] [ ] 49. Bentler PM. Comparative fit indexes in structural models. Psychol Bull 1990; 107(2): 238.## [ DOI:10.1037//0033-2909.107.2.238] [ PMID] 50. McDonald RP, Ho MH. Principles and practice in reporting structural equation analyses. Psychol Methods 2002; 7(1): 64.## [ DOI:10.1037//1082-989X.7.1.64] [ PMID] 51. Kline RB. Principles and practice of structural equation modeling: Guilford publications; 2015. ## 52. Mommersteeg PMC, Arts L, Zijlstra W, Widdershoven JW, Aarnoudse W, Denollet J. Impaired health status, psychological distress, and personality in women and men with nonobstructive coronary artery disease: sex and gender differences: the TWIST (Tweesteden Mild Stenosis) Study. Circ Cardiovasc Interv 2017; 10(2): 3387.## [ DOI:10.1161/CIRCOUTCOMES.116.003387] [ PMID] [ ] 53. Moser DK, Dracup K, Evangelista LS, Zambroski CH, Lennie TA, Chung ML, et al. Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung 2010; 39(5): 378-85.## [ DOI:10.1016/j.hrtlng.2009.10.017] [ PMID] [ ] 54. Ahmed S, Khan A, Ali SI, Saad M, Jawaid H, Islam M, et al. Differences in symptoms and presentation delay times in myocardial infarction patients with and without diabetes: A cross-sectional study in Pakistan. Indian Heart J 2018; 70(2): 241-5.## [ DOI:10.1016/j.ihj.2017.07.013] [ PMID] [ ] 55. Zargar F, Kavoosi M. Comparing anxiety sensitivity and metacognition beliefs in patients with irritable bowel syndrome and coronary heart diseases; a case-control study. Arch Psychiatry Psychother 2021; 2(2021): 53-60.## [ DOI:10.12740/APP/127308] 56. Mills SD, Fox RS, Malcarne VL, Roesch SC, Champagne BR, Sadler GR. The psychometric properties of the Generalized Anxiety Disorder-7 Scale in Hispanic Americans with English or Spanish language preference. Cult Divers Ethn Minor Psychol 2014; 20(3): 463.## [ DOI:10.1037/a0036523] [ PMID] [ ] 57. Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener(GAD-7) in the general population. Med Care 2008; 46(3): 266-74.## [ DOI:10.1097/MLR.0b013e318160d093] [ PMID] 58. Ruiz MA, Zamorano E, García-Campayo J, Pardo A, Freire O, Rejas J. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disord 2011; 128(3): 277-86.## [ DOI:10.1016/j.jad.2010.07.010] [ PMID] 59. Beard C, Björgvinsson T. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. J Anxiety Disord 2014; 28(6): 547-52.## [ DOI:10.1016/j.janxdis.2014.06.002] [ PMID] 60. Kertz S, Bigda‐Peyton J, Bjorgvinsson T. Validity of the Generalized Anxiety Disorder‐7 Scale in an acute psychiatric sample. Clin Psychol Psychother 2013; 20(5): 456-64.## [ DOI:10.1002/cpp.1802] [ PMID] 61. Bártolo A, Monteiro S, Pereira A. Factor structure and construct validity of the Generalized Anxiety Disorder 7-item (GAD-7) among Portuguese college students. Cad Saude Publica 2017; 33: e00212716.## [ DOI:10.1590/0102-311x00212716] [ PMID]
|